Reneo Pharmaceuticals is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. The company's goal is to improve daily function and quality of life of patients suffering from these diseases by improving mitochondrial function and preventing muscle injury, weakness, and wasting.
Market
Genetic mitochondrial diseases
Location
San Diego,
CA,
USA
Coinvestors
Lundbeckfonden Ventures, New Enterprise Associates, Pappas Capital, RiverVest Venture Partners